TACE Combined With Camrelizumab and Apatinib in Intermediate and Advanced Hepatocelluar Carcinoma
Clinical trial NCT04559607 · UNKNOWN
Trial details
- NCT number
- NCT04559607
- Sponsor
- Zhongda Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-11
- Primary completion
- 2024-08-31
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.